Tg(Prnp-ATXN3*70Q)70.61Olri
Transgene Detail
|
Symbol: |
Tg(Prnp-ATXN3*70Q)70.61Olri |
Name: |
transgene insertion 70.61, Olaf Riess |
MGI ID: |
MGI:5516451 |
Transgene: |
Tg(Prnp-ATXN3*70Q)70.61Olri Location: unknown
|
Alliance: |
Tg(Prnp-ATXN3*70Q)70.61Olri page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Prnp-ATXN3*70Q)70.61Olri expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
ATXN3 (4287) |
|
|
|
|
|
Mutation details: The mouse prion promoter (containing 1140 bp of the prion protein gene upstream of exon 1, the complete exon 1, intron 1, and the first 52 bp of exon 2) drives the expression of the full-length human ATAXIN-3 (ATAXIN-3c isoform that contains an additional ubiquitin-interacting motif at its C terminus) containing 70 CAG repeats. Four lines were created: 70.42, 70.48, 70.61, and 70.66.
(J:122993)
|
|
|
Key: |
hm |
homozygous |
ht |
heterozygous |
tg |
involves transgenes |
√ |
phenotype observed |
cn |
conditional genotype |
cx |
complex: > 1 genome feature |
ot |
other: hemizygous, indeterminate,... |
N |
normal phenotype |
|
Genotype/ Background: |
| Allelic Composition | Genetic Background | Cell Line(s) |
---|
Loading... | | | involves: C57BL/6N | |
|
Phenotypes: |
Affected Systems |
|
|
behavior/neurological
|
√
|
abnormal behavior
|
√
|
decreased grooming behavior
|
√
|
limb grasping
|
√
|
tremors
|
√
|
impaired coordination
|
√
|
abnormal gait
|
√
|
short stride length
|
√
|
decreased locomotor activity
|
√
|
growth/size/body
|
√
|
decreased body size
|
√
|
decreased body weight
|
√
|
hearing/vestibular/ear
|
N
|
hearing/vestibular/ear phenotype
|
N
|
mortality/aging
|
√
|
premature death
|
√
|
nervous system
|
√
|
abnormal cerebellum morphology
|
√
|
abnormal Purkinje cell morphology
|
√
|
neuronal intranuclear inclusions
|
√
|
abnormal nervous system physiology
|
√
|
skeleton
|
√
|
kyphosis
|
√
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Key: |
√ |
disease model |
|
 |
expected model not found |
|
Models:
|
Human Diseases |
IDs
Machado-Joseph disease
Close
|
√
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:122993 Bichelmeier U, et al., Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci. 2007 Jul 11;27(28):7418-28 |
All: |
2 reference(s) |
|